Clinuvel Pharmaceuticals LimitedASX: CUV

Change in substantial holding

· Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/change-in-substantial-holding-323

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call

604 Page 1 of 5 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company Name/Scheme CLINUVEL PHARMACEUTICALS LTD ACN/ARSN/ABN 88 089 644 119 1. Details of substantial holder (1) Name JPMorgan Chase & Co. and its affiliates ...

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

Later from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases